A long-term outbreak ofurinary tract-associated multiply resistant Providencia stuartii occurred in a large medical facility that included a 513-bed chronic care unit. The unique characteristics of this outbreak were that from within a single medical facility, P. stuartii with multiple serotypes, biotypes, and antibiograms could be identified. The organisms isolated had five different biotypes, seven different antibiograms, and two major serotypes. All of the organisms were susceptible to amikacin, cefamandole, and cefoxitin. Application of standard infection control measures impeded the spread of this outbreak, and it slowly terminated 16 months later.
Providencia stuartii appears to be emerging as a hospital-acquired pathogen in many respects similar to Pseudomonas aeruginosa and Serratia marcescens. P. stuartii has been reported in urinary tract infections, particularly after bladder catheterization (12) and burn infection (13) . Recently, the close relationship between P. stuartii and P. rettgeri has been reported (5, 9) . Many organisms that previously have been called P. rettgeri only on the basis of urea hydrolysis have been reclassified as P. stuartii on the basis of fermentation reactions (5, 9) . It is now necessary to review past records on P. rettgeri (1, 4) with this new classification in mind. The present communication describes a long-term outbreak of P. stuartii originating in a chronic care unit and eventually involving patients throughout the medical center.
MATERIALS AND METHODS
All organisms were obtained from specimens submitted to the Clinical Microbiology Laboratory at the North Chicago Veterans Administration Medical Center (NCVAMC). The bacteria were tested for antimicrobial susceptibility by the disk diffusion (2) and the tube dilution methods (11 (4) lists the biochemical characteristics of the P. rettgeri isolates in study. With this information, it can be determined that the organism in the latter outbreak was urea-positive P. stuartii (4) . Farmer et al. (5) reported a blood culture that grew both urea-positive and urea-negative isolates of P. stuartii. They speculated that the urease production was probably plasmid mediated; however, they did not attempt to show the existence of a plasmid. These reports give reason to review the literature on P. stuartii and P. rettgeri with their similarity in mind.
In the present report, disk diffusion susceptibility studies indicated that all of the strains were susceptible to amikacin, cefamandole, and cefoxitin. Some of the strains were susceptible to other antimicrobial agents; however, none was susceptible to gentamicin, an antimicrobial agent used extensively in this medical center. There is a report on emergence of gentamicinresistant P. stuartii during therapy with gentamicin (6). The minimal inhibitory concentrations of gentamicin, amikacin, cefamandole, and cefoxitin agreed with the disk diffusion results.
The two new broad-spectrum cephalosporins, cefamandole and cefoxitin, may be useful alter- The reservoir of the organism seems to be the infected patient. Several of the patients harbored the organism on their skin, throat, or fecal material as determined by routine cultures. This was in contrast to the work of Wenzel et al., who were unable to isolate the organism from stool cultures and only once from a throat culture among 14 patients sampled (13) . Since the control measures were initiated in the spring of 1978, only one new patient with resistant P. stuartii has been seen. This patient has been on one of the wards that contains several patients with resistant P. stuartii; however, this patient was not cultured in the past. New acquisitions of P. stuartii decreased, and no new isolates have been seen since January 1979.
